METHOD FOR ENHANCING THE INTEGRITY OF A PHARMACEUTICAL SUPPLY CHAIN

Abstract

ABSTRACT A method (100) for enhancing the integrity of a pharmaceutical supply chain. Further, the method comprising deploying a smart contract on a blockchain network to define roles for participants including raw material suppliers, manufacturers, distributors, and retailers. Further, the method (100) comprising the steps of storing information regarding each pharmaceutical product in the blockchain, including a unique identifier and associated participant IDs. Further, the method (100) comprising the steps of implementing a tracking mechanism within the smart contract to update the status of each pharmaceutical product as it progresses through the supply chain stages. Further, the method (100) comprising the steps of enabling real-time access to product status for all authorized participants through a shared ledger to ensure transparency and accountability. Further, the method (100) comprising the steps of recording all transactions and s

Specification

Description:FIELD OF THE DISCLOSURE
[0001] This invention generally relates to the field of supply chain management and logistics, and in particular relates to a method for enhancing pharmaceutical supply chain integrity through the use of blockchain technology, designed to improve transparency, accountability, and security while minimizing the risk of fraud and counterfeit products.
BACKGROUND
[0002] The subject matter discussed in the background section should not be assumed to be prior art merely as a result of its mention in the background section. Similarly, a problem mentioned in the background section or associated with the subject matter of the background section should not be assumed to have been previously recognized in the prior art. The subject matter in the background section merely represents different approaches, which in and of themselves may also correspond to implementations of the claimed technology.
[0003] The pharmaceutical supply chain is a complex network involving multiple stakeholders, includi , Claims:1. A method (100) for enhancing the integrity of a pharmaceutical supply chain, the method comprising the steps of:
deploying a smart contract on a blockchain network to define roles for participants including raw material suppliers, manufacturers, distributors, and retailers;
storing information regarding each pharmaceutical product in the blockchain, including a unique identifier and associated participant IDs;
implementing a tracking mechanism within the smart contract to update the status of each pharmaceutical product as it progresses through the supply chain stages;
enabling real-time access to product status for all authorized participants through a shared ledger to ensure transparency and accountability; and
recording all transactions and status updates in an immutable manner on the blockchain to prevent data manipulation.

2. The method (100) as claimed in claim 1, wherein the smart contract restricts access to specific operations based on the role of the participant, ensuring that only authorized in

Documents